Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$152K Sell
10,952
-33,901
-76% -$529K 0.23% 217
2026
Q1
$564K Buy
+44,853
New +$455K 0.51% 30
2024
Q4
Sell
-5,200
Closed -$30.8K 13
2024
Q3
$30.8K Buy
5,200
+1,300
+33% +$7.24K 0.01% 740
2024
Q2
$20.5K Buy
+3,900
New +$19.9K 0.01% 791

Other funds holding ADTN

nVerses Capital's ADTN Position: Q2 2026 in Review

nVerses Capital reduced its Adtran (ADTN) stake by 76% in Q2 2026, selling an estimated $529K and leaving 10,952 shares worth $152K. The position accounts for 0.23% of the portfolio, ranked #217.

nVerses Capital first reported a position in ADTN in Q2 2024 and has held it in 4 quarters since. The position peaked at $564K in Q1 2026. 168 funds tracked by Wall St. Rank hold ADTN as of Q2 2026.

  • nVerses Capital held 10,952 shares of Adtran worth $152K as of Q2 2026.
  • nVerses Capital sold 33,901 Adtran shares in Q2 2026, an estimated $529K.
  • Adtran made up 0.23% of nVerses Capital's portfolio in Q2 2026, its #217 holding.
  • nVerses Capital first reported a position in Adtran in Q2 2024 and has held it in 4 quarters since.
  • nVerses Capital's Adtran position peaked at $564K in Q1 2026.
  • 168 funds tracked by Wall St. Rank held Adtran as of Q2 2026.

Based on nVerses Capital's 13F filing for Q2 2026, filed 4 Aug 2026.